Under construction – not a live service
Sign in
Taking people in CroatiaNo phase

Studies blood vessel lining changes in people with coronary heart disease

Observes blood vessel function in adults with coronary heart disease before and after bypass surgery.

Plain-language title generated from the registry record
Registry title: Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

Key facts

Where
Osijek, CroatiaSee the site

Where in Croatia

  • Osijek University HospitalOsijek, CroatiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Josip Juraj Strossmayer University of Osijek
Trial code
NCT07451873
Record updated
9 March 2026
Original description
The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CVD, as well as identify new biomarkers for CVD.Read full original descriptionShow less

The Role of Glycocalyx and Oxidative Stress in Endothelial Function (Part 2)

The primary research objective of the project is to determine the role of eGC in microvascular reactivity in patients with coronary heart disease (CHD) before and after bypass grafting (cross-sectional study 2).The main objective of the project is to increase the excellence and interdisciplinarity of scientific work at MEFOS by connecting researchers from different scientific fields, improving conditions and resources for scientific work, and increasing international cooperation, in line with strategic objective 1: raising scientific excellence. The results of the project could provide pathophysiological insight into the development and maintenance of endothelial dysfunction in CVD, as well as identify new biomarkers for CVD.

Inclusion: adult patients of both sexes over 18 years of age; Caucasian; undergoing elective coronary artery bypass grafting (CABG); provided written informed consent.

Exclusion: emergency surgery; sepsis or severe systemic inflammation before surgery; therapies that could affect oxidative stress (e.g., high doses of corticosteroids); severe renal or hepatic insufficiency; serious comorbidities (e.g., active cancer); immunosuppression.

ClinicalTrials.gov NCT07451873